Martin Hillsten

Chief Executive Officer

C-suiteM

FI·FIN-FSA

Integrum AB Integrum AB Intergrum AB Intergrum AB

Cumul. flow

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the detailed record of transactions filed by Martin Hillsten, Chief Executive Officer. Director active across 4 companies, notably Integrum AB. Cumulatively, 3 reports have been recorded. The latest transaction was filed on 9 December 2025 — Purchase. Regulator: FIN-FSA. The full history is free.

Declarations3 total

Executives●PurchaseIIntergrum AB34FIN-FSA

M

Martin HillstenVerkställande direktör (VD)

€27,49129,002 shares@ €0.94790.013% mcap100.0% of flow

Aktie

FI:A003U537-1·9 Dec 2025

Ideal exit: 5 Sept 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseIIntegrum AB26FIN-FSA

M

Martin HillstenVerkställande direktör (VD)

€1,8272,501 shares@ €0.73060.0009% mcap19.3% of flow

BTA (betald tecknad aktie)

FI:A003U536-1·8 Dec 2025

Ideal exit: 4 Sept 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseIIntegrum AB32FIN-FSA

M

Martin HillstenVerkställande direktör (VD)

€7,66010,500 shares@ €0.72950.0036% mcap80.7% of flow

BTA (betald tecknad aktie)

FI:A003U391-1·1 Dec 2025

Ideal exit: 28 Aug 2026 (T+270)

FIN-FSA ↗

3 of 3 declarations

About Martin Hillsten

Martin Hillsten is the Chief Executive Officer of Integrum AB. He is responsible for the strategic and operational leadership of the company, which specializes in health solutions. Martin Hillsten is committed to leading Integrum toward sustainable growth and strengthening its market position through innovations in the healthcare sector.